Cargando…
Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues
BACKGROUND: Only limited data concerning hepatitis B (HBV) and C viruses (HCV) coinfection are available. Direct-acting antivirals (DAAs) may be more effective for HCV clearance than interferon (IFN)-based regimens with a risk of HBV reactivation. METHODS: We retrospectively enrolled 40 HBV/HCV-coin...
Autores principales: | Papadopoulos, Nikolaos, Papavdi, Maria, Pavlidou, Anna, Konstantinou, Dimitris, Kranidioti, Hariklia, Kontos, George, Koskinas, John, Papatheodoridis, George V., Manolakopoulos, Spilios, Deutsch, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924860/ https://www.ncbi.nlm.nih.gov/pubmed/29720863 http://dx.doi.org/10.20524/aog.2018.0255 |
Ejemplares similares
-
Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein
por: Deutsch, Melanie, et al.
Publicado: (2018) -
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
por: Manolakopoulos, Spilios, et al.
Publicado: (2015) -
Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors
por: Kranidioti, Hariklia, et al.
Publicado: (2015) -
Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting
por: Koustenis, Kanellos Rafail, et al.
Publicado: (2020) -
Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)